BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: FitzSimons D, Hendrickx G, Vorsters A, Van Damme P. Hepatitis A and E: update on prevention and epidemiology. Vaccine. 2010;28:583-588. [PMID: 19925903 DOI: 10.1016/j.vaccine.2009.10.136] [Cited by in Crossref: 64] [Cited by in F6Publishing: 56] [Article Influence: 4.9] [Reference Citation Analysis]
Number Citing Articles
1 Zhu F, Zhang J, Zhang X, Zhou C, Wang Z, Huang S, Wang H, Yang C, Jiang H, Cai J, Wang Y, Ai X, Hu Y, Tang Q, Yao X, Yan Q, Xian Y, Wu T, Li Y, Miao J, Ng M, Shih JW, Xia N. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. The Lancet 2010;376:895-902. [DOI: 10.1016/s0140-6736(10)61030-6] [Cited by in Crossref: 463] [Cited by in F6Publishing: 191] [Article Influence: 38.6] [Reference Citation Analysis]
2 Miyamura T. Hepatitis E virus infection in developed countries. Virus Res 2011;161:40-6. [PMID: 21443914 DOI: 10.1016/j.virusres.2011.03.006] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
3 Franco E, Meleleo C, Serino L, Sorbara D, Zaratti L. Hepatitis A: Epidemiology and prevention in developing countries. World J Hepatol 2012; 4(3): 68-73 [PMID: 22489258 DOI: 10.4254/wjh.v4.i3.68] [Cited by in Crossref: 157] [Cited by in F6Publishing: 112] [Article Influence: 15.7] [Reference Citation Analysis]
4 Zhang ZL, Zhu XJ, Shan AL, Gao ZG, Zhang Y, Ding YX, Liu H, Wu WS, Liu Y, He HY, Xie XH, Xia WD, Li C, Xu WT, Li ZY, Lin HL, Fu WM. Effectiveness of 10-year vaccination (2001-2010) on Hepatitis A in Tianjin, China. Hum Vaccin Immunother 2014;10:1008-12. [PMID: 24503599 DOI: 10.4161/hv.27775] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
5 Jiang W, Muhammad F, Ma P, Liu X, Long G. Sofosbuvir inhibits hepatitis A virus replication in vitro assessed by a cell-based fluorescent reporter system. Antiviral Research 2018;154:51-7. [DOI: 10.1016/j.antiviral.2018.04.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
6 Theamboonlers A, Abe K, Thongmee C, Poovorawan Y. Complete coding sequence and molecular analysis of hepatitis A virus from a chimpanzee with fulminant hepatitis. J Med Primatol 2012;41:11-7. [PMID: 22017331 DOI: 10.1111/j.1600-0684.2011.00515.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
7 Terio V, Tantillo G, Martella V, Pinto PD, Buonavoglia C, Kingsley DH. High Pressure Inactivation of HAV Within Mussels. Food Environ Virol 2010;2:83-8. [DOI: 10.1007/s12560-010-9032-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
8 Blachier M, Leleu H, Peck-Radosavljevic M, Valla DC, Roudot-Thoraval F. The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol. 2013;58:593-608. [PMID: 23419824 DOI: 10.1016/j.jhep.2012.12.005] [Cited by in Crossref: 744] [Cited by in F6Publishing: 666] [Article Influence: 82.7] [Reference Citation Analysis]
9 Forbi JC, Esona MD, Agwale SM. Molecular characterization of hepatitis A virus isolates from Nigeria. Intervirology. 2013;56:22-26. [PMID: 23052106 DOI: 10.1159/000341612] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
10 Lazcano-Ponce E, Conde-Gonzalez C, Rojas R, DeAntonio R, Romano-Mazzotti L, Cervantes Y, Ortega-Barria E. Seroprevalence of hepatitis A virus in a cross-sectional study in Mexico: Implications for hepatitis A vaccination. Hum Vaccin Immunother 2013;9:375-81. [PMID: 23291940 DOI: 10.4161/hv.22774] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
11 Jang JH, Jung YM, Kim JS, Lee SH, Kim JW, Hwang SG, Rim KS, Park SJ, Park YM, Kang SK, Lee HS, Yun H, Kim JH, Jeong SH. Coexistence of IgM antihepatitis A virus and IgM antihepatitis E virus in acute viral hepatitis: a prospective, multicentre study in Korea. J Viral Hepat 2011;18:e408-14. [PMID: 21914057 DOI: 10.1111/j.1365-2893.2011.01477.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
12 Annous BA, Buckley DA, Kingsley DH. Efficacy of Chlorine Dioxide Gas Against Hepatitis A Virus on Blueberries, Blackberries, Raspberries, and Strawberries. Food Environ Virol 2021;13:241-7. [PMID: 33689143 DOI: 10.1007/s12560-021-09465-1] [Reference Citation Analysis]
13 Karimi A, Mortazaei S, Moradi MT. High Prevalence of Symptomatic Hepatitis A Infection in Rural Area of Chaharmahal VA Bakhtiari Province, Iran. J Clin Diagn Res 2015;9:DC01-3. [PMID: 25859451 DOI: 10.7860/JCDR/2015/9798.5515] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
14 Kamal SM, Mahmoud S, Hafez T, El-Fouly R. Viral hepatitis a to e in South mediterranean countries. Mediterr J Hematol Infect Dis 2010;2:e2010001. [PMID: 21415943 DOI: 10.4084/MJHID.2010.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
15 Kurugol Z, Aslan A, Turkoglu E, Koturoglu G. Changing epidemiology of hepatitis A infection in Izmir, Turkey. Vaccine 2011;29:6259-61. [PMID: 21763745 DOI: 10.1016/j.vaccine.2011.06.069] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
16 Mohd Hanafiah K, Jacobsen KH, Wiersma ST. Challenges to mapping the health risk of hepatitis A virus infection. Int J Health Geogr. 2011;10:57. [PMID: 22008459 DOI: 10.1186/1476-072x-10-57] [Cited by in Crossref: 63] [Cited by in F6Publishing: 26] [Article Influence: 5.7] [Reference Citation Analysis]
17 Abarca K, Ibáñez I, de la Fuente P, Cerda L, Bergeret J, Frösner G, Ibarra H. Immunogenicity and tolerability of a paediatric presentation of a virosomal hepatitis A vaccine in Chilean children aged 1–16 years. Vaccine 2011;29:8855-62. [DOI: 10.1016/j.vaccine.2011.09.095] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
18 Hunter PR, Colón-González FJ, Brainard J, Majuru B, Pedrazzoli D, Abubakar I, Dinsa G, Suhrcke M, Stuckler D, Lim TA, Semenza JC. Can economic indicators predict infectious disease spread? A cross-country panel analysis of 13 European countries. Scand J Public Health 2020;48:351-61. [PMID: 31291826 DOI: 10.1177/1403494819852830] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
19 Esser-Nobis K, Harak C, Schult P, Kusov Y, Lohmann V. Novel perspectives for hepatitis A virus therapy revealed by comparative analysis of hepatitis C virus and hepatitis A virus RNA replication. Hepatology 2015;62:397-408. [PMID: 25866017 DOI: 10.1002/hep.27847] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
20 Yilmaz H, Karakullukcu A, Turan N, Cizmecigil UY, Yilmaz A, Ozkul AA, Aydin O, Gunduz A, Mete M, Zeyrek FY, Kirazoglu TT, Richt JA, Kocazeybek B. Genotypes of hepatitis a virus in Turkey: first report and clinical profile of children infected with sub-genotypes IA and IIIA. BMC Infect Dis 2017;17:561. [PMID: 28800730 DOI: 10.1186/s12879-017-2667-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
21 Yang L, Kiyohara T, Kanda T, Imazeki F, Fujiwara K, Gauss-Müller V, Ishii K, Wakita T, Yokosuka O. Inhibitory effects on HAV IRES-mediated translation and replication by a combination of amantadine and interferon-alpha. Virol J 2010;7:212. [PMID: 20815893 DOI: 10.1186/1743-422X-7-212] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
22 Amado Leon LA, de Almeida AJ, de Paula VS, Tourinho RS, Villela DA, Gaspar AM, Lewis-Ximenez LL, Pinto MA. Longitudinal Study of Hepatitis A Infection by Saliva Sampling: The Kinetics of HAV Markers in Saliva Revealed the Application of Saliva Tests for Hepatitis A Study. PLoS One 2015;10:e0145454. [PMID: 26690904 DOI: 10.1371/journal.pone.0145454] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
23 Debing Y, Neyts J, Thibaut HJ. Molecular biology and inhibitors of hepatitis A virus. Med Res Rev. 2014;34:895-917. [PMID: 23722879 DOI: 10.1002/med.21292] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
24 Watson J, Sjogren MH. Hepatitis A and E. In: Schiff ER, Maddrey WC, Sorrell MF, editors. Schiff's Diseases of the Liver. Oxford: Wiley-Blackwell; 2011. pp. 521-36. [DOI: 10.1002/9781119950509.ch23] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
25 Qi Y, Fan J, Huang W, Zhao C, Wang Y, Kong FT, Kong W, Jiang C. Expression and characterization of hepatitis E virus-like particles and non-virus-like particles from insect cells. Biotechnol Appl Biochem 2016;63:362-70. [PMID: 25824972 DOI: 10.1002/bab.1379] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
26 Hendrickx G, Vorsters A, Van Damme P. Advances in hepatitis immunization (A, B, E): public health policy and novel vaccine delivery. Curr Opin Infect Dis 2012;25:578-83. [PMID: 22907280 DOI: 10.1097/QCO.0b013e328357e65c] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
27 Yamamoto C, Ko K, Nagashima S, Harakawa T, Fujii T, Ohisa M, Katayama K, Takahashi K, Okamoto H, Tanaka J. Very low prevalence of anti-HAV in Japan: high potential for future outbreak. Sci Rep. 2019;9:1493. [PMID: 30728377 DOI: 10.1038/s41598-018-37349-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
28 Begde F, Orhon FS, Gerceker D, Ulukol B, Topcu S, Baskan S. Determining the persistence of maternally acquired antibodies to hepatitis A and varicella zoster during the first 2 years of life in Turkey. Eur J Pediatr 2015;174:883-90. [DOI: 10.1007/s00431-014-2484-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
29 Remondegui C, Ceballos S, Arce LP, Pintado E, Vidaurre R, Nitschko H, Osterman A, Vizoso Pinto MG. Serologic evidence of the circulation of the hepatitis E virus and the prevalence of antibodies against hepatitis A in an indigenous population in northern Argentina. Rev Argent Microbiol 2021:S0325-7541(21)00012-2. [PMID: 33648797 DOI: 10.1016/j.ram.2020.10.006] [Reference Citation Analysis]
30 Sotelo N. Pediatric viral hepatitis: avoiding liver failure. Pediatric Health 2010;4:613-22. [DOI: 10.2217/phe.10.52] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
31 Yan J, Kanda T, Wu S, Imazeki F, Yokosuka O. Hepatitis A, B, C and E virus markers in Chinese residing in Tokyo, Japan. Hepatol Res 2012;42:974-81. [PMID: 22524475 DOI: 10.1111/j.1872-034X.2012.01009.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
32 Kamani L, Padhani ZA, Das JK. Hepatitis E: Genotypes, strategies to prevent and manage, and the existing knowledge gaps. JGH Open 2021;5:1127-34. [PMID: 34621997 DOI: 10.1002/jgh3.12646] [Reference Citation Analysis]
33 Yun H, Lee HJ, Cheon D, Chu C, Oh KW, Kim YT, Jee Y. Seroprevalence of hepatitis a and e viruses based on the third Korea national health and nutrition survey in Korea. Osong Public Health Res Perspect 2011;2:46-50. [PMID: 24159450 DOI: 10.1016/j.phrp.2011.04.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
34 Jacobsen KH, Wiersma ST. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine. 2010;28:6653-6657. [PMID: 20723630 DOI: 10.1016/j.vaccine.2010.08.037] [Cited by in Crossref: 315] [Cited by in F6Publishing: 251] [Article Influence: 26.3] [Reference Citation Analysis]
35 Al-Naaimi AS, Turky AM, Khaleel HA, Jalil RW, Mekhlef OA, Kareem SA, Hasan NY, Dhadain AA. Predicting acute viral hepatitis serum markers (A and E) in patients with suspected acute viral hepatitis attending primary health care centers in Baghdad: a one year cross-sectional study. Glob J Health Sci 2012;4:172-83. [PMID: 22980390 DOI: 10.5539/gjhs.v4n5p172] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
36 Tourinho RS, de Almeida AJ, Villar LM, Murat PG, Capelin GJ, Castro AR, de Paula VS. Cross-Sectional Study of Hepatitis A Virus Infection in the Pantanal Population before Vaccine Implementation in Brazil: Usage of Non-Invasive Specimen Collection. Int J Environ Res Public Health 2015;12:7357-69. [PMID: 26133128 DOI: 10.3390/ijerph120707357] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
37 Blechová Z, Trojánek M, Kynčl J, Částková J, John J, Malý M, Herrmannová K, Marešová V. Clinical and laboratory features of viral hepatitis A in children. Wien Klin Wochenschr 2013;125:83-90. [DOI: 10.1007/s00508-012-0316-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
38 Parrón I, Planas C, Godoy P, Manzanares-Laya S, Martínez A, Sala MR, Minguell S, Torner N, Jané M, Domínguez A; Working Group for the Study of Hepatitis A in Catalonia. Effectiveness of hepatitis A vaccination as post-exposure prophylaxis. Hum Vaccin Immunother 2017;13:423-7. [PMID: 27925847 DOI: 10.1080/21645515.2017.1264798] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
39 Pereira S, Linhares I, Neves AF, Almeida A. Hepatitis A immunity in the District of Aveiro (Portugal): an eleven-year surveillance study (2002-2012). Viruses 2014;6:1336-45. [PMID: 24638206 DOI: 10.3390/v6031336] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
40 Amado LA, Villar LM, de Paula VS, Pinto MA, Gaspar AM. Exposure to multiple subgenotypes of hepatitis A virus during an outbreak using matched serum and saliva specimens. J Med Virol 2011;83:768-75. [PMID: 21412786 DOI: 10.1002/jmv.22045] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
41 Yang N, Chu DLH, Wong MML, Qi H, Wu RSS, Kong RYC. Major human Hepatitis A virus genotype in Hong Kong marine waters and detection by real-time PCR. Marine Pollution Bulletin 2011;62:2654-8. [DOI: 10.1016/j.marpolbul.2011.09.027] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
42 Halicioglu O, Akman SA, Tatar B, Atesli R, Kose S. Hepatitis A seroprevalence in children and adolescents aged 1–18 years among a low socioeconomic population in Izmir, Turkey. Travel Medicine and Infectious Disease 2012;10:43-7. [DOI: 10.1016/j.tmaid.2012.01.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
43 Shouval D. Hepatitis A Virus. In: Kaslow RA, Stanberry LR, Le Duc JW, editors. Viral Infections of Humans. Boston: Springer US; 2014. pp. 417-38. [DOI: 10.1007/978-1-4899-7448-8_17] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
44 Kingsley DH. High Pressure Processing of Bivalve Shellfish and HPP's Use as a Virus Intervention. Foods 2014;3:336-50. [PMID: 28234323 DOI: 10.3390/foods3020336] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
45 Rapicetta M, Monarca R, Kondili LA, Chionne P, Madonna E, Madeddu G, Soddu A, Candido A, Carbonara S, Mura MS, Starnini G, Babudieri S. Hepatitis E virus and hepatitis A virus exposures in an apparently healthy high-risk population in Italy. Infection 2013;41:69-76. [DOI: 10.1007/s15010-012-0385-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
46 Yanez LA, Lucero NS, Barril PA, Díaz Mdel P, Tenaglia MM, Spinsanti LI, Nates SV, Isa MB, Ré VE. Evidence of hepatitis A virus circulation in central Argentina: seroprevalence and environmental surveillance. J Clin Virol 2014;59:38-43. [PMID: 24332411 DOI: 10.1016/j.jcv.2013.11.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
47 Tsou T, Liu C, Huang J, Tsai K, Chang H. Change in hepatitis A epidemiology after vaccinating high risk children in Taiwan, 1995–2008. Vaccine 2011;29:2956-61. [DOI: 10.1016/j.vaccine.2011.02.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
48 Melgaço JG, Gardinali NR, de Mello VDM, Leal M, Lewis-Ximenez LL, Pinto MA. Hepatitis E: Update on Prevention and Control. Biomed Res Int 2018;2018:5769201. [PMID: 29546064 DOI: 10.1155/2018/5769201] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
49 Kim DH, Ahn HS, Go HJ, Kim DY, Kim JH, Lee JB, Park SY, Song CS, Lee SW, Choi IS. Heme Oxygenase-1 Exerts Antiviral Activity against Hepatitis A Virus In Vitro. Pharmaceutics 2021;13:1229. [PMID: 34452191 DOI: 10.3390/pharmaceutics13081229] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
50 Kingsley DH. High pressure processing and its application to the challenge of virus-contaminated foods. Food Environ Virol 2013;5:1-12. [PMID: 23412716 DOI: 10.1007/s12560-012-9094-9] [Cited by in Crossref: 53] [Cited by in F6Publishing: 33] [Article Influence: 5.3] [Reference Citation Analysis]
51 Yun H, Lee HJ, Yoon Y, Kim K, Kim S, Shin MH, Taniguchi M, Kim SR, Kim MK. Seroepidemiology of hepatitis a infection in northeastern china, Korea, and Japan. Osong Public Health Res Perspect 2012;3:31-5. [PMID: 24159484 DOI: 10.1016/j.phrp.2012.01.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
52 Cacciola I, Messineo F, Cacopardo B, Di Marco V, Galli C, Squadrito G, Musolino C, Saitta C, Pollicino T, Raimondo G. Hepatitis E virus infection as a cause of acute hepatitis in Southern Italy. Dig Liver Dis 2011;43:996-1000. [PMID: 21880560 DOI: 10.1016/j.dld.2011.07.017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
53 Cho GJ, Kim YB, Kim SM, Hong HR, Kim JH, Seol HJ, Hong SC, Oh MJ, Kim HJ. Hepatitis A virus infection during pregnancy in Korea: Hepatitis A infection on pregnant women. Obstet Gynecol Sci 2013;56:368-74. [PMID: 24396815 DOI: 10.5468/ogs.2013.56.6.368] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
54 Arya SC, Agarwal N. Re: Hepatitis A and E: Update on prevention and epidemiology. Vaccine 2010;28:2062. [PMID: 20044057 DOI: 10.1016/j.vaccine.2009.12.031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
55 Arcangeletti MC, Dussaix E, Ferraglia F, Roque-Afonso AM, Graube A, Chezzi C. Multicentric evaluation of new commercial enzyme immunoassays for the detection of immunoglobulin M and total antibodies against hepatitis A virus. Clin Vaccine Immunol 2011;18:1391-4. [PMID: 21653739 DOI: 10.1128/CVI.00403-10] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
56 Cao D, Meng XJ. Molecular biology and replication of hepatitis E virus. Emerg Microbes Infect 2012;1:e17. [PMID: 26038426 DOI: 10.1038/emi.2012.7] [Cited by in Crossref: 84] [Cited by in F6Publishing: 81] [Article Influence: 8.4] [Reference Citation Analysis]